Redirected perforin-dependent lysis of colon carcinoma by ex vivo genetically engineered CTL

Journal of Immunology

Volumn 164, Issue 7, 2000, Pages 3705-3712

  Darcy, Phillip K ^a   Haynes, Nicole M ^a   Snook, Marie B ^a   Trapani, Joseph A ^a   Cerruti, Loretta ^b   Jane, Stephen M ^b   Smyth, Mark J ^a  

^a AUSTIN RESEARCH INSTITUTE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FC RECEPTOR; GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; COLON CARCINOMA; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; GENE TARGETING; GENE TRANSFER; GENETIC ENGINEERING; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL;

EID: 0034177140     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.7.3705     Document Type: Article

References (42)

1. Rosenberg, S. A. 1988. Use of tumor-infiltrating lymphocytes and IL-2 in the immunotherapy of patients with metastatic melanoma. N. Engl. J. Med. 319: 1676.
2. Rosenberg, S. A. 1992. The immunotherapy and gene therapy of cancer. J. Clin. Oncol. 10:180.
3. Abken, H., A. Hombach, U. Reinhold, and S. Ferrone. 1998. Can combined T-cell-and antibody-based immunotherapy outsmart tumor cells. Immunol. Today 19:1.
4. Hwu, P., J. C. Yang, R. Cowherd, J. Treisman, G. E. Shafer, Z. Eshhar, and S. A. Rosenberg. 1995. In vivo anti-tumor activity of T cells redirected with chimeric antibody/T-cell receptor genes. Cancer Res. 55:3369.
5. Moritz, D., W. Wels, J. Mattern, and B. Groner. 1994. Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells. Proc. Natl. Acad. Sci. USA 91:4318.
6. Stancovski, I., D. G. Schindler, T. Waks, Y. Yarden, M. Sela, and Z. Eshhar. 1993. Targeting of T lymphocytes to Neu/HER2-expressing cells using chimeric single chain Fv receptors. J. Immunol. 151:6577.
7. Weijtens, M. E., R. A. Willemsen, D. Valerio, K. Stam, and R. L. Bolhuis. 1996. Single chain Ig/γ gene redirected human T lymphocytes produce cytokines, specifically lyse tumor cells, and recycle lytic activity. J. Immunol. 157:836.
8. Mezzanzanica, D., S. Canevari, A. Mazzoni, M. Figini, M. I. Colnaghi, T. Waks, D. G. Schindler, and Z. Eshhar. 1998. Transfer of chimeric receptor gene made of variable regions of tumor-specific antibody confers anticarbohydrate specificity on T cells. Cancer Gene Ther. 5:401.
9. Darcy, P. K., M. H. Kershaw, J. A. Trapani, and M. J. Smyth. 1998. Expression in cytotoxic T lymphocytes of a single-chain anti-carcinoembryonic antigen antibody: redirected Fas ligand-mediated lysis of colon carcinoma. Eur. J. Immunol. 28:1663.
10. Haynes, N. M., M. J. Smyth, M. H. Kershaw, J. A. Trapani, and P. K. Darcy. 1999. Fas-ligand-mediated lysis of erbB-2-expressing tumour cells by redirected cytotoxic T lymphocytes. Cancer Immunol. Immunother. 47:278.
11. Hege, K. M., K. S. Cooke, M. H. Finer, K. M. Zsebo, and M. R. Roberts. 1996. Systemic T cell-independent tumor immunity after transplantation of universal receptor-modified bone marrow into SCID mice. J. Exp. Med. 184:2261.
12. Horan Hand, P., P. F. Robbins, M. L. Salgaller, D. J. Poole, and J. Schlom. 1993. Evaluation of human carcinoembryonic-antigen (CEA)-transduced and non-transduced murine tumors as potential targets for anti-CEA therapies. Cancer Immunol. Immunother. 36:65.
13. Korner, H., M. Cook, D. S. Riminton, F. A. Lemckert, R. M. Hoek, B. Ledermann, F. Kontgen, B. Fazekas de St Groth, and J. D. Sedgwick. 1997. Distinct roles for lymphotoxin-α and tumor necrosis factor in organogenesis and spatial organisation of lymphoid tissue. Eur. J. Immunol. 278:2600.
14. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259:1739.
15. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytocoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31.
16. Chester, K. A., R. H. Begent, L. Robson, P. Keep, R. B. Pedley, J. A. Boden, G. Boxer, A. Green, G. Winter, O. Cochet, et al. 1994. Phage libraries for clinically useful antibodies. Lancet 343:455.
17. Vanin, E. F., L. Cerruti, N. Tran, G. Grosveld, J. M. Cunningham, and S. M. Jane. 1997. Development of high titer retroviral producer cell lines using Cre-mediated recombination. J. Virol. 71:7820.
18. Coligan, J. E., A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober. 1993. T cell enrichment by nonadherence to nylon. In Current Protocols in Immunology, eds. Wiley, J. & Sons, New York, pp. 3.2.1-3.2.3.
19. Evan, G. I., G. K. Lewis, G. Ramsay, and J. M. Bishop. 1985. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Cell. Biol. 5:3610.
20. Henkart, P. A. 1994. Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity 1:343.
21. Kershaw, M. H., P. K. Darcy, J. A. Trapani, and M. J. Smyth. 1996. The use of chimeric human Fc∈ receptor I to redirect cytotoxic T lymphocytes to tumours. J. Leukocyte Biol. 60:721.
22. Brocker, T., and K. Karjalainen. 1998. Adoptive tumor immunity mediated by lymphocytes bearing modified antigen-specific receptors. Adv. Immunol. 68:257.
23. Gross, G., T. Waks, and Z. Eshhar. 1989. Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity. Proc. Natl. Acad. Sci. USA 86:10024.
24. Begent, R. H., and K. A. Chester. 1997. Single-chain Fv antibodies for targeting cancer therapy. Biochem. Soc. Trans. 25:715.
25. Altenschmidt, U., E. Klundt, and B. Groner. 1997. Adoptive transfer of in vitro-targeted, activated T lymphocytes results in total tumor regression. J. Immunol. 159:5509.
26. Brocker, T., A. Peter, A. Traunecker, and K. Karjalainen. 1993. New simplified molecular design for functional T cell receptor. Eur. J. Immunol. 23:1435.
27. Eshhar, Z., T. Waks, G. Gross, and D. G. Schindler. 1993. Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the γ or ζ subunits of the immunoglobulin and T-cell receptors. Proc. Natl. Acad. Sci. USA 90:720.
28. Stancovski, I., D. G. Schindler, T. Waks, Y. Yarden, M. Sela, and Z. Eshhar. 1993. Targeting of T lymphocytes to Neu/HER2-expressing cells using chimeric single chain Fv receptors. J. Immunol. 151:6577.
29. Hwu, P., G. E. Shafer, J. Treisman, D. G. Schindler, G. Gross, R. Cowherd, S. A. Rosenberg, and Z. Eshhar. 1993. Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor y chain. J. Exp. Med. 178:361.
30. + T lymphocytes armed with universal T-cell receptors. Blood 84:2878.
31. Smyth, M. J., M. H. Kershaw, P. K. Darcy, and J. A. Trapani. 1998. Adoptive transfer: the role of perform in mouse cytotoxic T lymphocyte rejection of human tumor xenografts in vivo. Xenotransplantation 5:146.
32. Kagi, D., B. Odermatt, P. S. Ohashi, R. M. Zinkernagel, and H. Hengartner. 1996. Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity. J. Exp. Med. 183:2143.
33. + T cell-mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity. Eur. J. Immunol. 24:3068.
34. Lustgarten, J., J. Marks, and L. A. Sherman. 1999. Redirecting effector T cells through their IL-2 receptors. J. Immunol. 162:359.
35. Verhaar, M. J., C. A. Damen, B. A. Zonnenberg, and G. H. Blijham. 1999. In vitro upregulation of carcinoembryonic antigen expression by combinations of cytokines. Cancer Lett. 139:67.
36. Weijtens, M. E., R. A. Willemsen, B. A. van Krimpen, and R. L. Bolhuis. 1998. Chimeric scFv/γ receptor-mediated T-cell lysis of tumor cells is coregulated by adhesion and accessory molecules. Int. J. Cancer 77:181.
37. Hombach, A., R. Sircar, C. Heuser, T. Tillmann, V. Dichl, W. Kruis, C. Pohl, and H. Abken. 1998. Chimeric anti-TAG72 receptors with immunoglobulin constant Fc domains and γ or ζ signalling chains. Int. J. Mol. Med. 2:99.
38. + malignancy. Biol. Blood Marrow Transplant. 4:75.
39. Fitzer-Attas, C. J., D. G. Schindler, T. Waks, and Z. Eshhar. 1998. Harnessing Syk family tyrosine kinases as signaling domains for chimeric single chain of the variable domain receptors: optimal design for T cell activation. J. Immunol. 160: 145.
40. Holliger, P., O. Manzke, M. Span, R. Hawkins, B. Fleischmann, L. Qinghua, J. Wolf, V. Diehl, O. Cochet, G. Winter, and H. Bohlen. 1999. Carcinoembryonic antigen (CEA)-specific T-cell activation in colon carcinoma induced by anti-CD3 × anti-CEA bispecific diabodies and B7 × anti-CEA bispecific fusion proteins. Cancer Res. 59:2909.
41. Kass, E., J. Schlom, J. Thompson, F. Guadagni, P. Graziano, and J. W. Greiner. 1999. Induction of protective host immunity to carcinoembryonic antigen (CEA), a self-antigen in CEA transgenic mice, by immunizing with a recombinant vaccinia-CEA virus. Cancer Res. 59:676.
42. Hombach, A., D. Koch, R. Sircar, C. Heuser, V. Diehl, W. Kruis, C. Pohl, and H. Abken. 1999. A chimeric receptor that selectively targets membrane-bound carcinoembryonic antigen (mCEA) in the presence of soluble CEA. Gene Ther. 6:300.